Wednesday, November 23, 2022

GLP-1 Agonists for DM Management: Evidence Analysis

Dear Dr. Renukaprasad A R,
GLP-1 receptor agonists have driven a major shift in managing diabetes mellitus(DM) owing to the many benefits they offer, including cardioprotection, renal protection, and good hyperglycemic control.
Join Dr. Supratik Bhattacharyya, an expert endocrinologist, in an exclusive MasterSeries session on "GLP-1 Agonists in DM management: Comparative Analysis" TODAY, 3:00 PM IST onwards.
Docplexus is one of the world's largest online communities
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

No comments:

Post a Comment